Exicure, Inc.

NasdaqCM XCUR

Exicure, Inc. Market Capitalization on January 14, 2025: USD 26.20 M

Exicure, Inc. Market Capitalization is USD 26.20 M on January 14, 2025, a 203.74% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

Exicure, Inc. 52-week high Market Capitalization is USD 83.36 M on November 27, 2024, which is 218.20% above the current Market Capitalization.
Exicure, Inc. 52-week low Market Capitalization is USD 3.91 M on July 09, 2024, which is -85.08% below the current Market Capitalization.
Exicure, Inc. average Market Capitalization for the last 52 weeks is USD 12.80 M.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

NasdaqCM: XCUR

Exicure, Inc.

CEO	Mr. Paul Kang
IPO Date	May 22, 2018
Location	United States
Headquarters	2430 North Halsted Street
Employees	5
Sector	Health Care
Industries Biotechnology Pharmaceuticals

Description

Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie Inc. to develop SNA-based treatments for hair loss disorders; and collaboration agreement with Ipsen S.A. to research, develop, and commercialize novel spherical nucleic acids for Huntington's disease and Angelman syndrome. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.

Key trends

Past 5 years